Jeff Hackman is the Chief Executive Officer and Director of Fennec Pharmaceuticals, Inc. They have held senior leadership roles across multiple biopharma companies, including Interim CEO and Chief Operating Officer at Novelion Therapeutics (2017–2018), President, North America at EUSA Pharma (2018–2021), and Chairman and CEO of Comera Life Sciences (2021–2024). They oversaw the acquisition, integration, and divestiture of several companies, as well as the negotiation and execution of multiple partnerships and licensing deals. They earned a BA in Communications from Lycoming College (1980–1984).
This person is not in the org chart
This person is not in any teams
This person is not in any offices